Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8093)
All Articles published online
|
Publishing Process of This Article
|
Sep 7, 2018 (publication date) through Nov 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Garbuzenko DV, Arefyev NO, Kazachkov EL. Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives. World J Gastroenterol 2018; 24(33): 3738-3748 [PMID: 30197479 DOI: 10.3748/wjg.v24.i33.3738] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v24/i33/3738.htm |
| Number | Citing Articles |
| 1 |
Wolfgang Kreisel, Denise Schaffner, Adhara Lazaro, Jonel Trebicka, Irmgard Merfort, Annette Schmitt-Graeff, Peter Deibert. Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension. International Journal of Molecular Sciences 2020; 21(17): 6223 doi: 10.3390/ijms21176223
|
| 2 |
Hui Li. Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinoma. Expert Review of Gastroenterology & Hepatology 2021; 15(3): 217 doi: 10.1080/17474124.2021.1842732
|
| 3 |
Sheng-Hung Chen, Hsueh-Chou Lai, Wen-Pang Su, Jung-Ta Kao, Wei-Fan Hsu, Hung-Wei Wang, Hung-Yao Chen, Cheng-Yuan Peng. Liver stiffness and spleen stiffness predict distinct liver-related events after hepatitis C eradication with direct-acting antivirals. Journal of the Formosan Medical Association 2024; doi: 10.1016/j.jfma.2024.02.016
|
| 4 |
Hong Zhou, Han Hu, Maoyong Tian, Jun Chu, Caiyun Tian, Yanqing Yang, Shide Lin, Chiara Ricci. Validation and Refinement of the Baveno VI Criteria for Ruling Out High-Risk Varices. Gastroenterology Research and Practice 2020; 2020: 1 doi: 10.1155/2020/4217512
|
| 5 |
Sigita Gelman, Violeta Salteniene, Andrius Pranculis, Jurgita Skieceviciene, Romanas Zykus, Dalius Petrauskas, Limas Kupcinskas, Ali Canbay, Alexander Link, Juozas Kupcinskas. Plasma Nogo-A and placental growth factor levels are associated with portal hypertension in patients with liver cirrhosis. World Journal of Gastroenterology 2019; 25(23): 2935-2946 doi: 10.3748/wjg.v25.i23.2935
|
| 6 |
N. R. Matkovska. MORTALITY ANALYSIS OF THE PATIENTS WITH ALCOHOLIC LIVER CIRRHOSIS. International Journal of Medicine and Medical Research 2019; 5(1): 40 doi: 10.11603/ijmmr.2413-6077.2019.1.9857
|
| 7 |
D. V. Garbuzenko. Current strategies for targeted therapy of liver fibrosis. Bulletin of Siberian Medicine 2022; 21(3): 154 doi: 10.20538/1682-0363-2022-3-154-165
|
| 8 |
Xinyuan Wang, Juan Li, Jiao Nong, Xin Deng, Yiping Chen, Peibin Wu, Xiabing Huang. Curcumol Attenuates Portal Hypertension and Collateral Shunting Via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats. Biochemical Genetics 2024; doi: 10.1007/s10528-024-10684-x
|
| 9 |
Analysis of Causes of Death in Patients with Alcoholic Liver Cirrhosis Associated with Non-alcoholic Fatty Liver Disease. Family medicine 2019; (4): 47 doi: 10.30841/2307-5112.4.2019.184588
|
| 10 |
Dmitry Victorovich Garbuzenko, Nikolay Olegovich Arefyev. Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis: An update and review of the literature. Journal of Evidence-Based Medicine 2020; 13(4): 313 doi: 10.1111/jebm.12407
|
| 11 |
Adhara Lazaro, Patrick Stoll, Dominik von Elverfeldt, Wolfgang Kreisel, Peter Deibert. Close Relationship between Systemic Arterial and Portal Venous Pressure in an Animal Model with Healthy Liver. International Journal of Molecular Sciences 2023; 24(12): 9963 doi: 10.3390/ijms24129963
|
| 12 |
Xingyao Hu, Guangbin Shang, Jie Zhang, Zhong Chen, Liu Fu, Jun Li, Xiaonan Lu. Clinical Yi-guan decoction for liver cirrhosis. Medicine 2021; 100(13): e24530 doi: 10.1097/MD.0000000000024530
|
| 13 |
Chalermrat Bunchorntavakul, K. Rajender Reddy. Pharmacologic Management of Portal Hypertension. Clinics in Liver Disease 2019; 23(4): 713 doi: 10.1016/j.cld.2019.06.004
|
| 14 |
Eun Jeoung Lee, Yun Kim, Ji Eun Kim, Eileen Laurel Yoon, Sung Ryol Lee, Dae Won Jun. ALS-L1023 from Melissa officinalis Alleviates Liver Fibrosis in a Non-Alcoholic Fatty Liver Disease Model. Life 2022; 13(1): 100 doi: 10.3390/life13010100
|
| 15 |
Yanting Ye, Chao Xia, Hong Hu, Shihang Tang, Hui Huan. Metabolomics reveals altered metabolites in cirrhotic patients with severe portal hypertension in Tibetan population. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1404442
|
| 16 |
M. L. Katsin, M. Y. Hurava, Pavel S. Prylutski, A. M. Dzyadz’ko, O. O. Rummo. Pathogenesis and clinical significance of the hyperdynamic circulatory syndrome in liver cirrhosis. Review. Annals of Critical Care 2021; (1): 123 doi: 10.21320/1818-474X-2021-1-123-133
|